Drug Store News

SEPTEMBER 6, 2023

Pharmacy technicians are crucial to the accessibility and continuity of healthcare.

105

105

Pharmacy Times

SEPTEMBER 6, 2023

Norgestrel (Opill) for pregnancy prevention will be accessible at various retail locations, including drug stores, convenience stores, grocery stores, and online platforms.

Grocery Stores 123

Grocery Stores 123

Pharmacy Times

SEPTEMBER 7, 2023

There are common symptoms experienced in the workplace that may be linked to hormones instead of stress.

131

131

Drug Topics

SEPTEMBER 8, 2023

Vaxart’s VP1-based bivalent oral tablet vaccine was developed to target the norovirus GI.1 Norwalk and GII.4 Sydney strains, which are the predominant strains affecting humans.

Vaccines 187

Vaccines 187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 8, 2023

A diagnosis of ALS has long been seen as a death sentence. But in recent years, progress in the world of ALS research and drug development has come to embody a conundrum with far broader implications: The balance between moving aggressively on promising new cures and guarding against false hope.

FDA 145

FDA 145

Fierce Pharma

SEPTEMBER 7, 2023

Demand is so strong for Novo Nordisk’s obesity drugs that the only limitation on sales—in the short term—seems to be the company’s ability to produce them. | Promising heart data for Novo Nordisk's Wegovy are a "paradigm shift," according to J.P. Morgan, which has doubled its market projection for GLP-1 diabetes and obesity treatments to $71 billion for 2032.

139

139

Fierce Healthcare

SEPTEMBER 8, 2023

Intermountain Healthcare, a health system that operates 33 hospitals across seven western states, is transitioning from Oracle Health's Cerner electronic health record to rival Epic, citing higher | Intermountain Healthcare, a health system that operates 33 hospitals across seven western states, is transitioning from Oracle Health's Cerner EHR to its rival Epic, citing higher physician satisfaction scores as one key factor.

Cerner 132

Cerner Hospitals 132

STAT

SEPTEMBER 8, 2023

On a Friday afternoon in July, as many New Yorkers fled the scorching city streets, a couple of dozen out-of-towners descended on Times Square. They came bearing gold letter balloons spelling out LFVN, the stock symbol for LifeVantage, the company they’d come to promote, and foam cutouts of its navy blue supplement bottles. LifeVantage’s chief executive officer, Steve Fife, rang the Nasdaq exchange’s closing bell, a celebration of the Utah-based company’s new products

Vaccines 145

Vaccines 145

Fierce Pharma

SEPTEMBER 7, 2023

Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. | Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Analysts anticipate that the trend will continue in 2023 and into 2024 as companies attempt to beef up their portfolios.

135

135

Pharmacy Times

SEPTEMBER 7, 2023

Crovalimab achieved disease control and non-inferiority compared to eculizumab, which is the current standard-of-care for individuals with paroxysmal nocturnal hemoglobinuria.

FDA 149

FDA 149

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

SEPTEMBER 6, 2023

Chronic kidney disease (CKD) is a major blind spot for many Americans, a new survey suggests. | Though many respondents used the internet for medical information and had a regular doctor and blood work done once or twice a year, 58% of respondents were unfamiliar with the illness.

132

132

STAT

SEPTEMBER 7, 2023

The organization that runs the infectious diseases surveillance system ProMED terminated at least three of the program’s top moderators on Thursday. The three were leaders of a strike that began in early August — one that is scheduled to end on Monday. Longtime moderators Marjorie Pollack and Maria Jacobs, along with associate editor Leo Liu, received notification from ISID CEO Linda MacKinnon that their consulting agreements with the International Society for Infectious Disea

145

145

Fierce Pharma

SEPTEMBER 6, 2023

IBM disclosed "unauthorized access" to J&J’s Janssen CarePath patient assistance program, which helped over 1 million U.S. patients last year.

134

134

Pharmacy Times

SEPTEMBER 8, 2023

Applying novel and effective behavioral economics for pre-exposure prophylaxis dissemination programs could help to tailor the programs to the populations and settings of high HIV burden areas.

145

145

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

SEPTEMBER 6, 2023

YouTube announced two programs Thursday that the Google-owned video platform said will give healthcare content creators new opportunities to educate diverse audiences. | The two new initiatives leverage cultural representation and targeted messaging to reach audiences impacted by health inequity, Google's Garth Graham, M.D., said.

131

131

STAT

SEPTEMBER 7, 2023

A recent study prompted CNN to report, “Most cancer screenings don’t ultimately give someone extra time beyond their regular lifespan.” Does that mean it’s time to dismantle the cancer screening infrastructure in the United States? Probably not. The complex math behind screening befuddled the researchers’ attempts to assess whether screening helped people live longer, leading to unsupportable conclusions.

145

145

pharmaphorum

SEPTEMBER 7, 2023

In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions at Advanz Pharma and Mokhtar Elsayed, head of global go to market commercial transformation at Sano

122

122

Pharmacy Times

SEPTEMBER 8, 2023

Correctly diagnosing specific follicular lymphomas and marginal zone lymphomas requires knowledge of the clinical context, including the site of involvement, age, and clinical presentation.

145

145

Fierce Healthcare

SEPTEMBER 6, 2023

Unite Us, tech company focused on social determinants of health, lays off employees amid profitability struggles agliadkovskaya Wed, 09/06/2023 - 14:25

138

138

STAT

SEPTEMBER 6, 2023

BRISTOL, Va. — When Wes Adams’ youngest son was little, he’d sometimes toddle over to the TV, pop in a cassette, and watch himself being born. It was a home video, filmed by his older brother. There was his mother, her belly anesthetized but her head very much awake, asking the doctors to keep the incision small, please. There was his dad’s medical partner, making the cut for the C-section.

145

145

Fierce Pharma

SEPTEMBER 7, 2023

University of Pennsylvania spinout BlueWhale Bio has surfaced on a mission to smash bottlenecks in cell and gene therapy manufacturing. | Cell therapy manufacturer BlueWhale Bio uncloaked Thursday with news it has raised $18 million in seed financing. The funding round was led by Danaher Corporation.

121

121

Pharmacy Times

SEPTEMBER 6, 2023

The fixed-dose abacavir/dolutegravir/lamivudine combination is indicated for the once-daily treatment of children weighing at least 6 kg to <25 kg with HIV-1 infection.

FDA 139

FDA 139

Fierce Healthcare

SEPTEMBER 7, 2023

Value-based healthcare with two-sided risk led to a savings of about $14 million over two years, according to the Florida-based insurance plan and national primary care provider company that overse | The collaborative effort by Florida Blue and Aledade not only led to $14 million in savings, but also a reduction in hospitalizations and emergency department visits, according to the companies.

Insurance 125

Insurance Hospitals 125

STAT

SEPTEMBER 5, 2023

University of California graduate students were thrilled last December when they won what they thought were big pay increases after an unprecedented strike. Most of them could expect a 10% salary increase the first year of the new three-year contract, the university system said. But students contend it hasn’t worked out that way. Graduate students on some of the academic system’s 10 campuses are accusing their universities of wage theft, claiming they’re using sleight of han

Documentation 145

Documentation 145

Fierce Pharma

SEPTEMBER 7, 2023

Johnson & Johnson’s plan to expand decade-old pulmonary hypertension med Opsumit has hit a snag. | J&J’s Janssen has decided to stop a phase 3 trial for a high dose of Opsumit in a subtype of pulmonary hypertension. With the flop, J&J loses a chance to challenge Bayer's Adempas.

121

121

Pharmacy Times

SEPTEMBER 8, 2023

In addition to improving risk evaluation in older adults at home, point-of-care testing may help clinicians manage patients with dementia who cannot communicate and those living in depopulated areas.

Communication 132

Communication 132

Fierce Healthcare

SEPTEMBER 8, 2023

A trio of House committees unveiled new legislation (PDF) Friday to lower costs and increase transpar | Several house committees dropped new legislation Friday meant to improve price transparency for patients and employers. Here's what they're proposing.

124

124

STAT

SEPTEMBER 8, 2023

Heart disease is killing fewer Americans overall, however, cardiovascular deaths where obesity was listed as a key contributing factor have tripled between 1999 and 2020, according to a new study published Wednesday in the Journal of the American Heart Association. And, Black women had the highest mortality rate out of all the population groups studied.

144

144

Fierce Pharma

SEPTEMBER 5, 2023

Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act (IRA). | Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act. The case was filed Friday in New Jersey federal court, three days after the CMS revealed that Novartis’ heart failure treatment Entresto was among 10 drugs subject to price negotiations in 2026.

121

121

Pharmacy Times

SEPTEMBER 8, 2023

With pharmacies around the country shifting to provide more comprehensive care and becoming true health care destinations, Chichi Ilonzo Momah, PharmD, RPh said she is excited for the future of the field.

132

132

Fierce Healthcare

SEPTEMBER 6, 2023

The American Hospital Association (AHA) is among those pushing back against the Federal Trade Commission’s (FTC's) plans to update pre-merger notification requirements, calling the proposal “a subs | "There is no need to subject hospitals to burdensome rules aimed at other sectors of the economy,” the AHA wrote of amendments to the Hart-Scott-Rodino Form proposed in June.

Hospitals 124

Hospitals 124

STAT

SEPTEMBER 7, 2023

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients. Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer. This is a familiar but tiring refrain.

144

144

Fierce Pharma

SEPTEMBER 7, 2023

Thanks to a contract manufacturing deal with Takeda gone awry, AbbVie appears to be in line to receive hundreds of millions of dollars in damages. | The Delaware Court of Chancery sided with AbbVie in the damages portion of the case, granting the drugmaker nearly all of the $480.6 million it was seeking over a botched supply agreement for Lupron.

118

118

Pharmacy Times

SEPTEMBER 7, 2023

The importance of findability, accessibility, interoperability, and reusability has become even more significant to academics as government agencies increasingly require data openness and accessibility for funding eligibility.

132

132